Metso's illustrative financial information for 2012 and for

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Metso's illustrative financial information for 2012 and for January - September of 2013

Metso Corporation's stock exchange release on November 12, 2013 at 1:30 p.m. local time Metso Corporation's Extraordinary General Meeting approved a demerger plan on October 1, 2013, pursuant to which all the assets, debts, and liabilities relating to Metso's Pulp, Paper and Power businesses will transfer without liquidation to Valmet Corporation. Metso's Mining and Construction segment and Automation segment will form Metso's continuing operations. The demerger is expected to be registered in the Finnish Trade Register on or about December 31, 2013, after which Valmet shares will be admitted for public trading on NASDAQ OMX Helsinki on or about January 2, 2014. A prospectus relating to Valmet Corporation, an entity to be established as part of Metso's partial demerger, was published on September 23, 2013 and is available on Metso's website (www.metso.com). Basis of the Preparation of Unaudited Illustrative Financial Information The following unaudited illustrative financial information is presented to illustrate the result of operations and the financial position of Metso's continuing operations had the demerger taken place on January 1, 2012. The unaudited illustrative information in respect of Metso set out below is based upon financial information derived from Metso's audited consolidated financial statements as of and for the year ended December 31, 2012, restated for the impact of the adoption of revised IAS 19 "Employee Benefits", and from Metso's unaudited consolidated interim report as of and for the nine month period ended September 30, 2013. This unaudited illustrative information is presented for illustrative purposes only. Because of its nature, it addresses a hypothetical situation and does not represent the actual results of Metso's operations or financial position had the demerger been completed on January 1, 2012. This information is not intended to project Metso's operational results or financial position of Metso as of any future date. Management believes that the illustrative information presented in this release provides a relevant basis to present the result of operations and the financial position of the continuing Metso Group. The adjustments made in preparing this information are based on available information and assumptions. There is no certainty that the assumptions applied in preparing the unaudited illustrative information will prove correct. The following significant assumptions and adjustments to such historical information have been made in the preparation of the illustrative financial information for Metso's continuing operations: All the revenues, expenses, assets, and liabilities relating to the PPP business have been excluded from Metso's reported consolidated financial information. * The effects of certain intra-group arrangements that have been or will be undertaken by Metso prior to the demerger in order to achieve the planned legal group structures of both Metso and Valmet have been taken into account, as have the effects of certain refinancing measures, including a settlement of intra-group items between Metso and Valmet. The net settlement of the intra-group balances has been treated as an adjustment to cash and cash equivalents for consolidated balance sheet purposes (a decrease of EUR 102 million as of December 31, 2012 and an increase of EUR 51 million as of September 30, 2013), reflecting the cash amount to be paid by Metso to Valmet or vice versa to settle the balances. * The total amount of equity derived from Metso's historical equity balance shown in the illustrative consolidated balance sheets represents the amount of net assets attributable to the PPP business. The adjustments made to equity reflect the contemplated equity structure of Valmet Corporation as described in the demerger plan. Accounting treatment of the demerger The demerger will be accounted for as a disposal to owners in accordance with IFRIC 17, Distributions of non-cash assets to owners. Once the demerger takes place, the difference between the fair value of the PPP business and its book value in Metso's consolidated balance sheet will be recorded as a gain on distribution. The PPP business to be divested through the demerger will be presented as discontinued operations in Metso's financial reporting when shareholders have approved the demerger. KEY FIGURES FOR METSO GROUP / AFTER DEMERGER As at and for the nine As at and months' ended for the year  Sept.30,  ended EUR million   2013     Dec. 31, 2012 ----------------------------------------------------------------------------- Net sales, total   2,989     4,499 Operating profit   299     463 Profit before taxes   256     404 Amortization of intangible assets   -16     -20 Depreciation of tangible assets   -46     -57 Non-recurring items Capacity adjustment expenses   0     -12 Cost related to demerger process   -1     0 Other NRE   -21     0 EBITA, before non-recurring items   337     495 EBITA, % before NRE   11.3 %     11.0 % EBITDA   361     540 Earnings per share, EUR     1.21     1.82 Shares (Metso's outstanding shares, period average)   149,813,092     149,715,383 Balance sheet total   3,915     4,000 Equity   1,232     1,359 Interest-bearing liabilities   1,107     1,094 Net debt   491     385 Gearing   39.9 %     28.3 % ROCE before taxes   17.6 %     19.2 % ROCE after taxes   12.9 %     13.8 % Equity to assets ratio   36.5 %     n/a Orders received   2,962     4,432 Order backlog   2,078     2,269 Personnel, at the end of period   18,658     17,665 EBITA, before non- Operating profit + amortization + non-recurring recurring items: items EBITDA Operating profit + depreciation and amortization Earnings per share, EUR   Profit -------------------------------------------   Number of outstanding shares of Metso, average Net interest bearing Gearing, % liabilities  x 100 -----------------------------   Total equity Return on capital employed (ROCE)  before taxes, % Profit before taxes + interest and other financial   expenses   x 100 -------------------------------------------------------- Balance sheet total - non-interest bearing   liabilities Return on capital employed (ROCE)  after taxes, % Profit + interest and other financial   expenses     x 100 -------------------------------------------------------- Balance sheet total - non-interest bearing   liabilities Equity to assets ratio, %   Total equity           x 100 --------------------------------------------------------   Balance sheet total - advances received Metso is a global supplier of technology and services to customers in the process industries, including mining, construction, pulp and paper, power, and oil and gas. Our 30,000 professionals based in over 50 countries contribute to sustainability and deliver profitability to customers worldwide. Metso's shares are listed on the NASDAQ OMX Helsinki Ltd. www.metso.com, www.twitter.com/metsogroup Further information, please contact: Juha Rouhiainen,VP, Investor relations, Metso Corporation, tel +358 20 484 3253 Metso Corporation Harri Nikunen CFO Juha Rouhiainen VP, Investor Relations Distribution: NASDAQ OMX Helsinki Ltd Media www.metso.com [HUG#1742415]

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 20

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 31

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 24

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 30

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 35

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 32

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 31

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading

Top 5 Most Recently Viewed Articles

Zepp Health Corp Posts Mixed Q3 Results Amid Product Launches

Updated Category News Views 104

Financial Overview of Zepp Health Corporation's Third Quarter Zepp Health Corporation (NYSE: ZEPP) recently released its unaudited financial results for the third quarter. The company's revenues totaled $42.5 million with a basic and diluted net loss per share recorded at $0.05, translating to a net loss of $13.3 million. Notably, these figures reflect a challenge the...

Continue Reading
Artea Bank to Ignite Third Fund for Apartment Building Renovation

Updated Category News Views 235

Artea Bank Launches New Fund for Multi-Apartment Building Renovations AB Artea Bankas has announced its intention to establish a third fund aimed at modernizing multi-apartment buildings. This initiative follows a notification from the European Investment Bank (EIB), signaling the start of negotiations for this new venture. Projected assets for the fund are substantial,...

Continue Reading
Insights on PROCEPT BioRobotics Quarterly Earnings Forecast

Updated Category News Views 172

Expected Earnings Report for PROCEPT BioRobotics PROCEPT BioRobotics (NASDAQ: PRCT) has set the stage for its next quarterly earnings report, which is eagerly anticipated by investors. The earnings release is scheduled for an upcoming Monday, an event that this company looks forward to with optimism. Market analysts currently predict that PROCEPT BioRobotics will post an...

Continue Reading
Akebia Therapeutics' New Stock Offering Aims for Growth

Updated Category News Views 172

Akebia Unveils New Public Offering of Common Stock Akebia Therapeutics, Inc. (Nasdaq: AKBA), a dedicated biopharmaceutical company focused on improving the lives of individuals affected by kidney disease, has publicly announced the pricing details of its recent offering. This offering involves 25 million shares of common stock, each priced at $2.00, aiming to generate...

Continue Reading
Crédit Agricole SA Announces Adjustment in Liquidity Contract

Updated Category News Views 113

Crédit Agricole SA Adjusts Liquidity Contract with Kepler Cheuvreux In a significant move, Crédit Agricole S.A. has announced a reduction of resources available for its liquidity contract with Kepler Cheuvreux. This shift aims to enhance the market activity surrounding the shares of the company, providing better stability and trading conditions in the financial market....

Continue Reading